Skip to main content
Molecular Medicine Reports logoLink to Molecular Medicine Reports
. 2017 Dec 12;17(2):3432. doi: 10.3892/mmr.2017.8276

Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro

Masayoshi Yamaguchi, Tomiyasu Murata
PMCID: PMC5783533  PMID: 29257315

Mol Med Rep 12: 7801-7805, 2015; DOI: 10.3892/mmr.2015.4352

Following the publication of this article, the authors noted that Fig. 1 appeared incorrectly in the journal. Essentially, the figure was reorganized but only the labels for Fig. 1B and C were switched around, with the result that Fig. 1B and C were labelled incorrectly in the paper.

Figure 1.

Figure 1.

Exogenous regucalcin suppresses the proliferation of MDA-MB-231 cells in vitro. Cells were cultured in the presence or absence of regucalcin (0.1–10 nM) for (A) 1, (B) 2, (C) 3 or (D) 7 days. Following culture, the number of cells were counted. Data are presented as the mean ± standard deviation of 2 replicate wells per data set using different dishes and cell preparations. *P<0.001 vs. control (grey bar). One way analysis of variance and the Tukey-Kramer post-test were used.

The corrected figure is shown below, with the figure parts for Fig. 1B and C now labelled correctly. This error was introduced into the figure during the pre-press stages. The editorial office wishes to apologize to the authors for this mistake, and we regret the inconvenience this mistake has caused.


Articles from Molecular Medicine Reports are provided here courtesy of Spandidos Publications

RESOURCES